Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages

J Immunol. 2000 Jun 1;164(11):5746-52. doi: 10.4049/jimmunol.164.11.5746.

Abstract

Macrophages represent an important effector cell for Ab-mediated tumor therapy. Previous studies have documented that cytokines can influence Fc receptor (FcR) expression and function. In this study we examined the tumoricidal activities of the type I receptors for IgG (Fc gamma RI) and the IgA FcR (Fc alpha RI) on monocyte-derived macrophages (MDM) cultured in the presence of IFN-gamma, M-CSF, or GM-CSF. Bispecific Abs were used to target a Her2/neu breast carcinoma cell line, SKBR-3, to Fc alpha RI or Fc gamma RI on MDM. Although Fc alpha RI and Fc gamma RI share a common signaling pathway contingent on association with the gamma-chain (FcR gamma subunit), a marked difference in their efficiency in mediating tumoricidal functions was seen in response to specific cytokines. M-CSF- and GM-CSF-treated MDM mediated efficient phagocytosis of SKBR-3 cells by Fc alpha RI and Fc gamma RI; however, IFN-gamma-treated MDM phagocytosed tumor cells only with the Fc gamma RI-directed bispecific Abs. Similarly, IFN-gamma-cultured MDM lysed tumor cells more efficiently via Fc gamma RI then by Fc alpha RI as measured in Ab-dependent cellular cytotoxicity assays. Conversely, GM-CSF-treated MDM mediated more efficient lysis of tumor cells via Fc alpha RI than Fc gamma RI, while M-CSF-cultured MDM were relatively less efficient in mediating Ab-dependent cellular cytotoxicity through either receptor. With the exception of IFN-gamma-mediated enhancement of Fc gamma RI expression and Fc gamma RI gamma-chain complexes, the regulation of Fc gamma RI- or Fc alpha RI-mediated activity occurred without significant change in either receptor expression or total complexes with gamma subunit. These data suggest that the efficiency of Ab-mediated tumor therapy, which depends on FcR effector cell functions, may be modified by the use of specific cytokines.

Publication types

  • Comparative Study

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adult
  • Antibodies, Bispecific / pharmacology
  • Antibody-Dependent Cell Cytotoxicity / immunology*
  • Antigens, CD / physiology*
  • Cell Differentiation / immunology
  • Cell Survival / immunology
  • Cytokines / pharmacology*
  • Cytotoxicity Tests, Immunologic / methods
  • Flow Cytometry
  • Humans
  • Immunoglobulin A / metabolism*
  • Macrophages / cytology
  • Macrophages / immunology*
  • Monocytes / cytology
  • Monocytes / immunology*
  • Phagocytosis / immunology
  • Receptors, Fc / physiology*
  • Receptors, IgG / physiology*
  • Tumor Cells, Cultured / immunology

Substances

  • Adjuvants, Immunologic
  • Antibodies, Bispecific
  • Antigens, CD
  • Cytokines
  • Fc(alpha) receptor
  • Immunoglobulin A
  • Receptors, Fc
  • Receptors, IgG